Federal Multi Criteria Decision Making Framework in Distribution of Anti-SARS-CoV-2 Monoclonal Antibody to Eligible High-Risk Patients as Case Study
No specific treatment was available for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) when the epidemic firstly broke out. The urgent need to end this unusual situation has resulted in many attempts to deal with SARS-CoV-2. In addition to several types of vaccinations that have been c...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| منشور في: |
2022
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://bspace.buid.ac.ae/handle/1234/2112 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|